Biorasis

company

About

Biorasis commercializes wireless, needle implantable, miniaturized sensor platforms for real-time glucose monitoring.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$696.40K
Industries
Biotechnology,Health Care,Internet,Wireless
Founded date
Dec 1, 2007
Number Of Employee
11 - 50
Operating Status
Active

BIORASIS was established in Dec. 2007 with an initial goal to commercialize UCONN’s and OSCI’s wireless, needle-implantable, miniaturized (0.5 x 0.5 x 5 mm) sensor platform for real time, continuous glucose monitoring.

In addition to glucose monitoring Biorasis is working towards outfitting its sensor platform to monitor other bio-analytes in the body that are important in other disorders such as cardiovascular, cancer, liver, kidney abnormalities, stroke and epilepsy.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$696.40K
Biorasis has raised a total of $696.40K in funding over 2 rounds. Their latest funding was raised on Aug 27, 2012 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 27, 2012 Grant $696.40K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Biorasis is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant